...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents.
【24h】

Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents.

机译:来自薄片蛋白D和康普他汀A 4的新型杂种作为细胞毒剂。

获取原文
获取原文并翻译 | 示例

摘要

A new series of hybrids of lamellarin D and combretastatin A 4, 1,2-diphenyl-5,6-dihydropyrrolo [2,1-a] isoquinolines, were designed as cytotoxic agents based on principles of combination in medicinal chemistry and taking the parent compounds' different anti-proliferative mechanisms into consideration. Twenty-two novel hybrids were synthesized through a convenient route, with a key step of core pyrrole formation and evaluated for their anti-proliferative activities in vitro against K-562, A-549, SMMC-7721, SGC-7901 and HCT-116 cancer cell lines. The results showed that some hybrids had good anti-proliferative activities in low IC50 ranges.
机译:基于药物化学结合原理并以其母体为基础,设计了一系列新的lamellarin D和comretretatin A 4,4,1,2-diphenyl-5,6-dihydropyrrolo [2,1-a]异喹啉杂化物作为细胞毒剂。化合物具有不同的抗增殖机制。通过便利的途径合成了22种新型杂种,该杂种具有核心吡咯形成的关键步骤,并评估了它们在体外对K-562,A-549,SMMC-7721,SGC-7901和HCT-116的抗增殖活性癌细胞系。结果表明,某些杂种在低IC50范围内具有良好的抗增殖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号